Penn Medicine Provider
Infectious Diseases
Brendan J. Kelly, MD
4.7
(30)
Accepting new patients
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program

About me

  • Assistant Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
  • Assistant Professor of Epidemiology in Biostatistics and Epidemiology
  • Assistant Professor of Medicine in Microbiology

Education and training

  • Medical School: Columbia University
  • Residency: NewYork-Presbyterian/Columbia University Medical Center
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.7

30 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2023
5.0
5.0
patient, kind, so intelligent. best doctor i've ever met
February 2023
5.0
5.0
he took time listened explained things
January 2023
5.0
5.0
we have a great connection
November 2022
5.0
5.0
i trust dr. kelly with a complicated problem

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Kelly is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Yarbrough ML, Dumm RE, Bry L, Kelly BJ, Schwartz D, Uberoi A. Microbiome-Based Diagnostics for Disease: Where Are We Now and Where Are We Headed? , Clin Chem, 70(6): 2024,792-797


Emilia C. Wilkins, Laura L. Cowden, Anne Jaskowiak-Barr, Lauren Dutcher, Brendan J. Kelly Stability of gut microbial community composition among donors to a clinical fecal microbiota transplant program , American Society for Microbiology (ASM) Microbe 2024 (Atlanta, GA, United States)., 14(1): 2024,155


Matthew J. Ziegler, Leigh Cressman, Anne Jaskowiak-Barr, Pam Tolomeo, , Brendan J. Kelly Post-antibiotic risk for recurrent lower respiratory tract infection during prolonged hospitalisation , European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2024 (Barcelona, Spain).: 2024


Tanneti NS, Patel AK, Tan LH, Marques AD, Perera RAPM, Sherrill-Mix S, Kelly BJ, Renner DM, Collman RG, Rodino K, Lee C, Bushman FD, Cohen NA, Weiss SR. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating , mBio, 15(3): 2024,e0312923


Marques AD, Graham-Wooten J, Fitzgerald AS, Sobel Leonard A, Cook EJ, Everett JK, Rodino KG, Moncla LH, Kelly BJ, Collman RG, Bushman FD. SARS-CoV-2 evolution during prolonged infection in immunocompromised patients , mBio, 15(5): 2024,e0011024


Kelly BJ, Kwon JH, Woodworth MH. Escape Velocity - The Launch of Microbiome Therapies , J Infect Dis, 230(1): 2024,2-4


Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden C, Cressman L, Huang E, Patel A, Lautenbach E, Kelly BJ Screening and targeted prophylaxis for Clostridioides difficile infection: STOP-CDI. , Infectious Diseases Society of America, IDWeek. Oral Presentation; 2024 Oct; Los Angeles, CA.: 2024


Ziegler MJ, Anesi J, Tolomeo P, Glaser L, Cowden L, Cressman L, Huang E, Patel A, Lautenbach E, Kelly BJ Screening and Targeted Prophylaxis for Clostridioides difficile Infection: STOP-CDI , Submitted and under review.: 2024


Wilkins EC, Loughrey S, Patel A, Anesi J, Kelly BJ Metagenomic Profiling Reveals Post-Kidney Transplant Urinary Microbiome Change , Submitted and under review.: 2024


Andy UU, Wilson NG, Bittinger K, Kreines FM, Arya LA, Kelly BJ Impact of Fecal Microbiota Transplantation on Recipients with High Baseline Gut Bacterial Community Diversity: a Pilot Trial , Submitted and under review.: 2024


View all publications